There are no peer-reviewed studies supporting any weight loss claims for GLP-1 patches
This can lead to a reversal of the condition in some patients, offering hope for those with this prevalent liver issue
However, implementation of this model in Medicare faces an uncertain future, since CMS has not yet announced specific plans to restart or restructure the model for future years
Thats why our approach goes beyond the prescription
Remarkably, data even losing 5% of body weight 22 can improve heart health metricssuch as triglycerides, total cholesterol, and low-density lipoprotein (LDL) cholesterolthereby reducing heart disease risk
Some observers have opined that the European agency is stricter than the US Food and Drug Administration, which has not yet addressed this issue